225 related articles for article (PubMed ID: 1682385)
1. A form of circulating ICAM-1 in human serum.
Rothlein R; Mainolfi EA; Czajkowski M; Marlin SD
J Immunol; 1991 Dec; 147(11):3788-93. PubMed ID: 1682385
[TBL] [Abstract][Full Text] [Related]
2. Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune diseases and lack of association with cICAM-1.
Martin S; Rieckmann P; Melchers I; Wagner R; Bertrams J; Voskuyl AE; Roep BO; Zielasek J; Heidenthal E; Weichselbraun I
J Immunol; 1995 Feb; 154(4):1951-5. PubMed ID: 7836774
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease.
Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
Leukemia; 1993 Aug; 7(8):1245-9. PubMed ID: 8102418
[TBL] [Abstract][Full Text] [Related]
4. Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1.
Meyer DM; Dustin ML; Carron CP
J Immunol; 1995 Oct; 155(7):3578-84. PubMed ID: 7561056
[TBL] [Abstract][Full Text] [Related]
5. Characterization of molecular interactions between intercellular adhesion molecule-1 and leukocyte function- associated antigen-1.
Woska JR; Morelock MM; Jeanfavre DD; Bormann BJ
J Immunol; 1996 Jun; 156(12):4680-5. PubMed ID: 8648112
[TBL] [Abstract][Full Text] [Related]
6. The role of LFA-1 (CD11a/CD18) cytoplasmic domains in binding to intercellular adhesion molecule-1 (CD54) and in postreceptor cell spreading.
Pyszniak AM; Carpenito C; Takei F
Exp Cell Res; 1997 May; 233(1):78-87. PubMed ID: 9184078
[TBL] [Abstract][Full Text] [Related]
7. Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection.
Lang T; Krams SM; Villanueva JC; Cox K; So S; Martinez OM
Transplantation; 1995 Feb; 59(4):584-9. PubMed ID: 7533349
[TBL] [Abstract][Full Text] [Related]
8. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
9. Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation-induced death of antigen-specific CD4+ T lymphocytes.
Damle NK; Klussman K; Leytze G; Aruffo A; Linsley PS; Ledbetter JA
J Immunol; 1993 Sep; 151(5):2368-79. PubMed ID: 7689606
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of circulating intercellular adhesion molecule-3 (cICAM-3) in Psoriasis.
Griffiths CE; Boffa MJ; Gallatin WM; Martin S
Acta Derm Venereol; 1996 Jan; 76(1):2-5. PubMed ID: 8721479
[TBL] [Abstract][Full Text] [Related]
11. CD45 mAb induces cell adhesion in peripheral blood mononuclear cells via lymphocyte function-associated antigen-1 (LFA-1) and intercellular cell adhesion molecule 1 (ICAM-1).
Lorenz HM; Harrer T; Lagoo AS; Baur A; Eger G; Kalden JR
Cell Immunol; 1993 Mar; 147(1):110-28. PubMed ID: 8096435
[TBL] [Abstract][Full Text] [Related]
12. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro.
Böhmig GA; Kovarik J; Holter W; Pohanka E; Zlabinger GJ
J Immunol; 1994 Apr; 152(8):3720-8. PubMed ID: 7511657
[TBL] [Abstract][Full Text] [Related]
13. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1.
Reilly PL; Woska JR; Jeanfavre DD; McNally E; Rothlein R; Bormann BJ
J Immunol; 1995 Jul; 155(2):529-32. PubMed ID: 7608533
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure.
Mrowka C; Sieberth HG
Clin Nephrol; 1995 May; 43(5):288-96. PubMed ID: 7543387
[TBL] [Abstract][Full Text] [Related]
15. Dominant-negative effect of the lymphocyte function-associated antigen-1 beta (CD18) cytoplasmic domain on leukocyte adhesion to ICAM-1 and fibronectin.
Rey-Ladino JA; Pyszniak AM; Takei F
J Immunol; 1998 Apr; 160(7):3494-501. PubMed ID: 9531311
[TBL] [Abstract][Full Text] [Related]
16. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
17. Engagement of ICAM-1 by major group rhinoviruses activates the LFA-1/ICAM-3 cell adhesion pathway in mononuclear phagocytes.
Kirchberger S; Vetr H; Majdic O; Stockinger H; Stöckl J
Immunobiology; 2006; 211(6-8):537-47. PubMed ID: 16920492
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.
Harning R; Mainolfi E; Bystryn JC; Henn M; Merluzzi VJ; Rothlein R
Cancer Res; 1991 Sep; 51(18):5003-5. PubMed ID: 1680025
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma concentrations of circulating intercellular adhesion molecule-1 (cICAM-1) in patients with necrotizing pancreatitis.
Kaufmann P; Tilz GP; Smolle KH; Demel U; Krejs GJ
Immunobiology; 1996 Jul; 195(2):209-19. PubMed ID: 8877397
[TBL] [Abstract][Full Text] [Related]
20. Characterization of murine intercellular adhesion molecule-2.
Xu H; Bickford JK; Luther E; Carpenito C; Takei F; Springer TA
J Immunol; 1996 Jun; 156(12):4909-14. PubMed ID: 8648141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
